OrthoPediatrics Corp. $KIDS Shares Sold by Granahan Investment Management LLC

Granahan Investment Management LLC trimmed its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 663,981 shares of the company’s stock after selling 95,970 shares during the period. Granahan Investment Management LLC owned 2.65% of OrthoPediatrics worth $11,792,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Russell Investments Group Ltd. raised its position in shares of OrthoPediatrics by 433.1% in the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after buying an additional 1,139 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC acquired a new stake in shares of OrthoPediatrics in the third quarter valued at about $54,000. BNP Paribas Financial Markets raised its position in shares of OrthoPediatrics by 60.2% in the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock valued at $61,000 after buying an additional 1,235 shares during the last quarter. Finally, State of Wyoming raised its position in shares of OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock valued at $121,000 after buying an additional 4,467 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Trading Up 2.1%

Shares of KIDS opened at $18.53 on Wednesday. The company has a current ratio of 5.21, a quick ratio of 2.37 and a debt-to-equity ratio of 0.29. OrthoPediatrics Corp. has a 12-month low of $14.42 and a 12-month high of $23.70. The firm has a 50-day moving average price of $17.21 and a 200 day moving average price of $17.42. The firm has a market capitalization of $475.94 million, a P/E ratio of -11.03 and a beta of 1.03.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Thursday, April 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.04. OrthoPediatrics had a negative net margin of 16.31% and a negative return on equity of 7.01%. The firm had revenue of $59.36 million during the quarter, compared to analyst estimates of $58.29 million. Sell-side analysts forecast that OrthoPediatrics Corp. will post -1.13 EPS for the current year.

Wall Street Analysts Forecast Growth

KIDS has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. Truist Financial set a $17.00 target price on shares of OrthoPediatrics in a research report on Friday, May 1st. Canaccord Genuity Group set a $25.00 price objective on shares of OrthoPediatrics in a report on Friday, April 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a report on Tuesday, April 21st. Finally, TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a report on Monday. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, OrthoPediatrics currently has a consensus rating of “Moderate Buy” and a consensus price target of $24.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.